Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma

Due to the poor prognosis of advanced metastatic melanoma, it is crucial to find early biomarkers that help identify which melanomas will metastasize. By comparing the gene expression data from primary and cutaneous melanoma samples from The Cancer Genome Atlas (TCGA), we identified GPC6 among a set...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuanyuan, Li, Melissa, Shats, Igor, Krahn, Juno M., Flake, Gordon P., Umbach, David M., Li, Xiaoling, Li, Leping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568403/
https://www.ncbi.nlm.nih.gov/pubmed/31199813
http://dx.doi.org/10.1371/journal.pone.0218067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568403/
https://www.ncbi.nlm.nih.gov/pubmed/31199813
http://dx.doi.org/10.1371/journal.pone.0218067

Ejemplares similares